17.34
price down icon2.20%   -0.39
after-market  After Hours:  17.405  0.065   +0.37%
loading
Walgreens Boots Alliance Inc stock is currently priced at $17.34, with a 24-hour trading volume of 10.76M. It has seen a -2.20% decreased in the last 24 hours and a -11.26% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $17.71 pivot point. If it approaches the $17.30 support level, significant changes may occur.
Previous Close:
$17.73
Open:
$17.414
24h Volume:
10.76M
Market Cap:
$14.96B
Revenue:
$144.60B
Net Income/Loss:
$-6.04B
P/E Ratio:
-4.8571
EPS:
-3.57
Net Cash Flow:
$-1.77B
1W Performance:
-2.64%
1M Performance:
-11.26%
6M Performance:
-15.95%
1Y Performance:
-49.90%
1D Range:
Value
$17.25
$17.68
52W Range:
Value
$17.25
$34.60

Walgreens Boots Alliance Inc Stock (WBA) Company Profile

Name
Name
Walgreens Boots Alliance Inc
Name
Phone
847-315-2500
Name
Address
108 Wilmot Road, Deerfield, IL
Name
Employee
244,000
Name
Twitter
@WBA_Global
Name
Next Earnings Date
2024-03-28
Name
Latest SEC Filings
Name
WBA's Discussions on Twitter

Walgreens Boots Alliance Inc Stock (WBA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-03-24 Initiated Barclays Underweight
Dec-22-23 Initiated HSBC Securities Hold
Oct-23-23 Upgrade JP Morgan Neutral → Overweight
Jul-03-23 Reiterated Morgan Stanley Underweight
Jun-28-23 Downgrade Deutsche Bank Buy → Hold
Feb-23-23 Initiated Loop Capital Buy
Nov-23-22 Resumed Morgan Stanley Underweight
Nov-22-22 Upgrade Cowen Market Perform → Outperform
Nov-18-22 Upgrade JP Morgan Neutral → Overweight
Nov-11-22 Upgrade Deutsche Bank Hold → Buy
Apr-01-22 Downgrade Robert W. Baird Outperform → Neutral
Dec-16-21 Downgrade Morgan Stanley Equal-Weight → Underweight
Mar-25-21 Reiterated Deutsche Bank Hold
Jan-11-21 Upgrade Guggenheim Neutral → Buy
Jan-11-21 Upgrade Robert W. Baird Neutral → Outperform
Jan-08-21 Resumed Credit Suisse Neutral
Apr-06-20 Upgrade UBS Sell → Neutral
Apr-03-20 Upgrade Deutsche Bank Sell → Hold
Dec-11-19 Downgrade Wells Fargo Outperform → Market Perform
Oct-30-19 Reiterated Pivotal Research Group Hold
Oct-23-19 Downgrade JP Morgan Overweight → Neutral
Sep-27-19 Resumed RBC Capital Mkts Sector Perform
Sep-12-19 Initiated Deutsche Bank Sell
Apr-18-19 Initiated Guggenheim Neutral
Apr-03-19 Downgrade Loop Capital Buy → Hold
Apr-03-19 Reiterated Pivotal Research Group Hold
Mar-08-19 Reiterated BofA/Merrill Underperform
Jan-17-19 Initiated UBS Sell
Dec-19-18 Resumed Wolfe Research Peer Perform
Dec-14-18 Downgrade Goldman Neutral → Sell
Oct-15-18 Reiterated Pivotal Research Group Hold
Oct-08-18 Reiterated RBC Capital Mkts Outperform
Jul-10-18 Downgrade Evercore ISI Outperform → In-line
Jul-09-18 Downgrade Citigroup Buy → Neutral
Jul-02-18 Reiterated Pivotal Research Group Hold
Jun-29-18 Downgrade Robert W. Baird Outperform → Neutral
View All

Walgreens Boots Alliance Inc Stock (WBA) Financials Data

Walgreens Boots Alliance Inc (WBA) Revenue 2024

WBA reported a revenue (TTM) of $144.60 billion for the quarter ending February 29, 2024, a +8.48% rise year-over-year.
loading

Walgreens Boots Alliance Inc (WBA) Net Income 2024

WBA net income (TTM) was -$6.04 billion for the quarter ending February 29, 2024, a -92.02% decrease year-over-year.
loading

Walgreens Boots Alliance Inc (WBA) Cash Flow 2024

WBA recorded a free cash flow (TTM) of -$1.77 billion for the quarter ending February 29, 2024, a -279.84% decrease year-over-year.
loading

Walgreens Boots Alliance Inc (WBA) Earnings per Share 2024

WBA earnings per share (TTM) was -$7.00 for the quarter ending February 29, 2024, a -91.78% decline year-over-year.
loading

Walgreens Boots Alliance Inc Stock (WBA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Mahajan Manmohan
EVP and Global CFO
Apr 02 '24
Buy
19.38
6,000
116,280
166,969
Walgreens Boots Alliance, Inc.
10% Owner
Feb 07 '24
Sale
235.41
4,212,395
991,639,907
26,277,561
JARRETT VALERIE B
Director
Jan 29 '24
Buy
22.44
4,456
99,993
4,456
SCHLICHTING NANCY M
Director
Jan 16 '24
Sale
23.05
15,209
350,567
0
WENTWORTH TIMOTHY C
Chief Executive Officer
Jan 05 '24
Buy
24.22
10,000
242,220
585,122
Gates Richard P.
SVP, Chief Pharmacy Officer
Nov 10 '23
Sale
20.45
1,000
20,450
73,929
Walgreens Boots Alliance, Inc.
10% Owner
Nov 09 '23
Sale
195.38
1,279,590
249,999,896
30,489,956
Walgreens Boots Alliance, Inc.
10% Owner
Aug 03 '23
Sale
189.27
1,320,858
250,000,115
31,769,546
DRISCOLL JOHN PATRICK
EVP, Pres. U.S. Healthcare
Jun 30 '23
Buy
28.42
5,172
146,984
59,050
Walgreens Boots Alliance, Inc.
10% Owner
Jun 15 '23
Sale
181.17
275,984
50,000,021
33,090,404
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services and mail services; and manages in-store clinics. As of August 31, 2018, this segment operated 9,560 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,767 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 618 optical practices, including 167 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in the United Kingdom, Germany, France, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
$2.19
price down icon 4.37%
pharmaceutical_retailers YI
$1.05
price up icon 0.96%
$3.96
price up icon 0.25%
$1.17
price down icon 1.68%
$5.975
price up icon 0.25%
Cap:     |  Volume (24h):